ArticleJournal of enzyme inhibition and medicinal chemistry2020

Reprofiling of pyrimidine-based DAPK1/CSF1R dual inhibitors: identification of 2,5-diamino-4-pyrimidinol derivatives as novel potential anticancer lead compounds.

Ahmed K Farag et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.